Expansion potential High growth female-founded health tech with a current revenue range of 100M-250M and recent product expansion into at-home diagnostics offers cross-sell opportunities to healthcare partners, pharmacies, and digital health platforms seeking gyne health solutions.

At-home diagnostics Second generation tampon enabling at-home detection of vaginal infections, STIs, and HPV creates multiple collaboration paths with telemedicine providers, clinics, and consumer health ecosystems seeking convenient, retentive testing solutions.

Tech enablement Tech stack including Power BI, Docker, Kubernetes, and customer platforms (HubSpot, Klaviyo, Zendesk) indicates strong data, CRM, and customer support capabilities suitable for enterprise partnerships, integrations, and scaled marketing campaigns.

Women’s health focus Mission to close gender health gaps and plans to address endometriosis, PCOS, and menopause position Daye as a partner for pharmaceutical companies, clinical trials, and patient advocacy groups seeking targeted gynae health solutions.

Scale readiness Moderate-size team (51-200 employees) with demonstrated product traction (over 100k users) suggests readiness for channel partnerships, white-label deals, and OEM-style collaborations to accelerate distribution and market reach.